Safety and effectiveness of nitroprusside in preventing no-reflow during percutaneous coronary intervention: a systematic review
Q Su, L Li, KA Naing, Y Sun - Cell biochemistry and biophysics, 2014 - Springer
The objective of this study was to evaluate the clinical efficacy and safety of nitroprusside
injection for preventing the slow-flow/no-reflow phenomenon after percutaneous coronary …
injection for preventing the slow-flow/no-reflow phenomenon after percutaneous coronary …
[HTML][HTML] The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon after primary percutaneous coronary intervention
B Zhao, J Li, X Luo, Q Zhou, H Chen… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
We prospectively studied the correlations between plasma levels of von Willebrand factor
and its cleaving protease—a disintegrin and metalloproteinase with thrombospondin type I …
and its cleaving protease—a disintegrin and metalloproteinase with thrombospondin type I …
[PDF][PDF] 冠状动脉内注射血塞通对ST 段抬高型急性心肌梗死介入术中缓再流现象的影响
甘立军[1， 张春卉， 张猛， 程云涛， 廖玉华 - 中国中西医结合杂志, 2010 - cjim.cn
摘要目的对照观察冠状动脉内注射血塞通(三七总皂甙) 对ST 段抬高型急性心肌梗死(STEMI)
介入术中缓再流现象的疗效, 不良反应及对患者预后的影响. 方法选取39 例接受经皮冠状动脉腔 …
介入术中缓再流现象的疗效, 不良反应及对患者预后的影响. 方法选取39 例接受经皮冠状动脉腔 …
[PDF][PDF] 冠脉内注射法舒地尔预防急性心肌梗死原发经皮介入治疗中慢血流及无复流的效果
隋春兴， 王超， 孙世泽， 郑晓群 - 中国老年学杂志, 2015 - chasesun.cn
目的观察冠脉内注射法舒地尔预防急性ST 段抬高型心肌梗死(STEMI) 患者经皮冠脉内介入治疗
(PCI) 术中慢血流/无复流的有效性, 安全性. 方法首发STEMI 且具备无复流高危因素患者82 例 …
(PCI) 术中慢血流/无复流的有效性, 安全性. 方法首发STEMI 且具备无复流高危因素患者82 例 …